Tools for Practice Outils pour la pratique


#84 Cranberry Juice/Tablets for the Prevention of Urinary Tract Infection: Naturally the Best?


CLINICAL QUESTION
QUESTION CLINIQUE
Does cranberry juice or extract prevent recurrent urinary tract infections (UTI)?


BOTTOM LINE
RÉSULTAT FINAL
Available evidence for cranberry products for reduction of UTIs is poor and inconsistentFunding or selective reporting influence the few positive results.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
Two systematic reviews1,2 and 5 randomized controlled trials (RCTs),3-7 in mostly female patients followed ~6 months 
  • Cochrane:1 24 RCTs (13 RCTs with juice/concentrate, 10 tablets/capsules and 1 both), 4473 patients 
    • 13 RCTs meta-analyzed: 
      • No significant difference in number of patients getting >1 UTI, relative risk (RR) 0.86 (0.71-1.04) 
      • No difference in subgroups (recurrent UTI, elderly, catheterized, pregnant, or children). 
    • Studies not meta-analyzed: 8 found no benefit, 2 found benefit 
    • RCTs at high risk of bias: For example, 75% of RCTs excluded patients from analysis and 46% lost >20% of patients. 
  • Archives:2 13 RCTs (8 RCTs of juice/concentrate, 4 tablets/capsules, and 1 both), 1616 patients 
    • Statistically significant reduction in UTIs, RR 0.62 (0.49-0.80), number needed to treat (NNT)=12 to avoid recurrent UTI 
      • Excluded one negative outlier trial but included the one positive outlier trialIf positive outlier excluded, results no longer significant 
    • Issues: Poorer quality literature search, poor-quality RCTs (as above), and selective analysis.
  • 3 RCTs of women with recurrent UTI: 
    • 176 patients:3 No difference in UTI (cranberry juice 27.5%, placebo 30.4%, p=0.70) 
    • 213 patients:4 No difference in UTI (cranberry juice 29.9%, placebo 35.8%, p=0.13) 
    • 373 patients:5 Statistically significant reduction iUTI 
      • Cranberry juice 18%, placebo 27%, NNT=12. 
    • A cranberry juice manufacturer sponsored the only RCT of the three with positive results (the others were not industry sponsored).  
Context:  
  • Proposed active ingredient in cranberry (A-type proanthocyanidins) is believed to inhibit adherence of Escherichia coli to the urogenital mucosa.1,2 Clinically unproven. 
  • Cranberry juice/cocktail costs ~$0.45-0.66 and contains 120-150 Calories per 250 mL 
    • Assuming 2 cups/day and the most positive data:2,5 One in 12 chance of avoiding UTI over 6 months would cost ~$180 and ~45,000 Calories (5.8 kg potential weight gain). 
  • Cranberry products likely inferior to antibiotics 
    • RCT of 221 women with recurrent UTI: Statistically significant more UTIs over 12 months for cranberry capsules (4/woman) versus trimethoprim-sulfamethoxazole (1.8/woman).6 
Ricky Turgeon BSc(Pharm) ACPR PharmD updated aug 10 2016


Latest Tools for Practice
Derniers outils pour la pratique

#363 Making a difference in indifference? Medications for apathy in dementia

In patients with dementia, how safe and effective are stimulants, antidepressants, and antipsychotics for treating apathy?
Read Lire 0.25 credits available Crédits disponibles

#362 Facing the Evidence in Acne, Part I: Oral contraceptives and spironolactone in females

How effective are combined oral contraceptives (COC) and spironolactone for treating acne of at least mild-moderate severity in females?
Read Lire 0.25 credits available Crédits disponibles

#361 Preventing RSV Infections in Infants

How safe and effective are monoclonal antibodies to prevent respiratory syncytial virus (RSV) infections in infants?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • G. Michael Allan MD CCFP
  • Lindsay Nicolle MD FRCP

1. Jepson RG, Williams G, Craig JC. Cochrane Database Syst Rev 2012;10:CD001321.

2. Wang CH, Fang CC, Chen NC, et al. Arch Intern Med 2012;172:988-96.

3. Stapleton AE, Dziura J, Hooton TM, et al. Mayo Clin Proc 2012;87:143-50.

4. Takahashi S, Hamasuna R, Yasuda M, et al. J Infect Chemother 2013;19:112-7.

5. Maki KC, Kaspar KL, Khoo C, et al. Am J Clin Nutr 2016;103:1434-42.

6. Beerepoot MA, ter Riet G, Nys S, et al. Arch Intern Med 2011;171:1270-8.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.